XML 20 R5.htm IDEA: XBRL DOCUMENT v3.26.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2026
Dec. 31, 2025
Current Assets:    
Cash and Cash Equivalents $ 412,708 $ 432,174
Accounts and Notes Receivable:    
Trade Receivables, net 369,889 349,233
Other Receivables, net 37,071 53,928
Inventories 369,080 374,759
Other Current Assets 82,063 130,128
Total Current Assets 1,270,811 1,340,222
Total Property, Plant and Equipment—Net 4,375,493 4,386,882
Other Assets:    
Funds for Asset Retirement Obligations 149,887 148,874
Pension Benefits 51,334 49,618
Other Noncurrent Assets, net 208,396 204,457
Total Other Assets 409,617 402,949
Total Assets 6,055,921 6,130,053
Current Liabilities:    
Accounts Payable 315,129 335,623
Current Portion of Long-Term Debt 43,418 98,328
Other Accrued Liabilities 388,425 404,338
Total Current Liabilities 746,972 838,289
Long-Term Liabilities:    
Long-Term Debt 411,630 354,160
Postretirement Benefits Other Than Pensions 186,732 186,843
Pneumoconiosis Benefits 258,926 261,201
Asset Retirement Obligations 495,140 496,002
Workers’ Compensation 71,419 70,457
Pension Benefits 20,997 21,111
Deferred Income Taxes 129,819 130,113
Other Noncurrent Liabilities 77,394 93,643
Total Long-Term Liabilities 1,652,057 1,613,530
Total Liabilities 2,399,029 2,451,819
Commitments and Contingent Liabilities (Note 14)
Stockholders' Equity:    
Common Stock, $0.01 Par Value; 125,000,000 Shares Authorized, 50,569,806 Shares Issued and Outstanding at March 31, 2026; 50,975,185 Shares Issued and Outstanding at December 31, 2025 506 510
Capital in Excess of Par Value 2,978,068 2,982,077
Retained Earnings 800,652 818,476
Accumulated Other Comprehensive Loss (122,334) (122,829)
Total Stockholders’ Equity 3,656,892 3,678,234
Total Liabilities and Stockholders’ Equity $ 6,055,921 $ 6,130,053